NCT06727708 Comparison of Two BioCircuit Programs: Impact on Physical Fitness and Body Composition in Adults Aged 30-65
| NCT ID | NCT06727708 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Graz |
| Condition | Muscle Strength |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2024-10-31 |
| Primary Completion | 2025-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2024-10-31 with a primary completion date of 2025-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the effects of two BioCircuit training programmes, 'Tone Your Body' and 'Boost Performance', on physical fitness and body composition in adults aged 30-65 years. Participants will be randomized to one of the two exercise programmes and will undergo a 12-week intervention with baseline and post-intervention measurements of fitness and body composition. The study aims to determine which programme is more effective in improving overall physical fitness, muscle mass and reducing body fat.
Eligibility Criteria
Inclusion Criteria: * • Age between 30 and 65 years * Healthy individuals without significant medical conditions * Less than 6 months of prior strength training experience * Willing and able to participate in a 12-week training program * Capable of performing strength training exercises such as leg press and chest press * Able to provide written informed consent Exclusion Criteria: * • History of coronary heart disease * History of stroke * Need for changes in antihypertensive treatment within 3 months prior to study start * Arthritis * Pregnancy or less than three months postpartum * Pain and movement restrictions * Use of medications that affect muscle strength or performance (e.g., anabolic steroids, beta-2 agonists, glucocorticoids, statins, benzodiazepines, ACE inhibitors, angiotensin-II receptor blockers, diuretics) * Any medical condition preventing participation in planned endurance and strength training
Contact & Investigator
Martin Atia
PRINCIPAL INVESTIGATOR
University of Graz
Frequently Asked Questions
Who can join the NCT06727708 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 65 Years, studying Muscle Strength. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06727708 currently recruiting?
Yes, NCT06727708 is actively recruiting participants. Contact the research team at atia.martin@hotmail.com for enrollment information.
Where is the NCT06727708 trial being conducted?
This trial is being conducted at Leibnitz, Styria, Austria.
Who is sponsoring the NCT06727708 clinical trial?
NCT06727708 is sponsored by University of Graz. The principal investigator is Martin Atia at University of Graz. The trial plans to enroll 42 participants.